Results for tag: "Breast Cancer Lumpectomy"

A lumpectomy is a surgical procedure undertaken as part of the treatment for breast cancer. It involves removing a breast tumor and a small margin of surrounding tissue while preserving as much of the breast as possible. As breast cancer is one of the most common cancers affecting women, lumpectomies constitute an important segment within the women's health market. This procedure is often preferred over a mastectomy, where the entire breast is removed, as it can achieve similar outcomes in early-stage cancers while being less invasive and preserving the breast's appearance, which can have positive effects on a patient's psychological well-being and quality of life. Treatment decisions are made on a case-by-case basis, taking into account the characteristics of the cancer, patient preferences, and other health factors. Advances in screening and early detection, as well as improvements in surgical techniques and adjuvant therapies, have contributed to the evolution of lumpectomy as a standard care option. Lumpectomy, coupled with radiation therapy or other treatments, offers a less radical approach than mastectomy, with a focus on balancing oncological safety with cosmetic outcomes. Some notable companies operating in the breast cancer lumpectomy market include Johnson & Johnson, Becton, Dickinson and Company (BD), Stryker Corporation, Hologic Inc., and Medtronic. These companies provide various products and solutions used in lumpectomy procedures, ranging from surgical instruments to imaging and diagnostic tools that facilitate tumor localization and precise surgery planning. Show Less Read more